Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Treatment of ALS: Controversy and Consensus

Sunday 04/25/04
06:45 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Breakfast Seminar
Robert G. Miller, MD
Neuromuscular and Clinical Neurophysiology (EMG)
Upon completion:
Participants should be able to manage patients with ALS using modern methods of palliative care and pharmacotherapy.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
06:45 AM - 07:15 AM Pharmacotheraphy : ALS
Hiroshi Mitsumoto, MD, FÂ鶹´«Ã½Ó³»­
07:15 AM - 07:45 AM Palliative Care : ALS
Robert G. Miller, MD
07:45 AM - 08:15 AM End of Life Issuses : ALS
Wendy Johnston, MD, FRCP(C), FÂ鶹´«Ã½Ó³»­
08:15 AM - 08:30 AM Questions and Answers
Faculty Disclosures
Robert G. Miller, MD The institution of Dr. Miller has received research support from Nurown.
No disclosure on file
Hiroshi Mitsumoto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mitsumoto has nothing to disclose.
Wendy Johnston, MD, FRCP(C), FÂ鶹´«Ã½Ó³»­ Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.